Biodexa Pharmaceuticals Plc (BDRX) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biodexa Pharmaceuticals Plc  (NASDAQ: BDRX)


Biodexa Pharmaceuticals Plc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biodexa Pharmaceuticals Plc's ROI in the fourth quarter of 2025?
Biodexa Pharmaceuticals Plc recorded a cumulative net loss of $-6 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -38.08%.

Within the Healthcare sector 537 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 4100.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 35.46 % 37.96 % 48.71 % 79.74 % 107.11 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 18 16 16 16 12
Return On Investment (TTM) -38.08 % -37.82 % -40.5 % -42.83 % -46.29 %
BDRX's Overall Ranking # 4100 # 0 # # #
Seq. Investment Change TTM 10.68 % 7.07 % 5.76 % 8.08 % 12.72 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -6 -6 -6 -6 -6

BDRX Company Profile >> Back to BDRX Roi Comparisons >> See Annual BDRX Return On Investment



Return On Investment BDRX's Ranking
Within: No.
Industry # 226
Sector # 538
Overall # 4100

Return On Investment Statistics
High Average Low
-32.63 %
-109.61 %
-324.97 %
(Dec 31 2017)   (Dec 31 2020)







Financial Statements
Biodexa Pharmaceuticals Plc's IV. Quarter Investments $ 18 Millions BDRX's Balance sheet
Biodexa Pharmaceuticals Plc's IV. Quarter Income $ -6 Millions Quarterly BDRX's Income Statement
BDRX's Income by Division See BDRX's Income by Division


BDRX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 16 12 6 4 11
Y / Y Investment Growth 34.93 % 89.32 % 46.11 % -62.07 % 64.36 %
Net Income in Millions -8 -7 -9 -9 -8
Y / Y Net Income Growth - - - - -
Annual Return On Investment -52.7 % -61.82 % -140.76 % -221.2 % -66.57 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BDRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BDRX's Competitors
Subscribers only: Roi for Biodexa Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Investment for BDRX's Customers

Other Ratios
BDRX's Roa BDRX's Inventory Turnover Ratio BDRX's Growth Rates BDRX's Dividend Statistics
BDRX's Profitability Ratios BDRX's Asset Turnover Ratio BDRX's Dividend Growth
BDRX's Roe BDRX's Valuation Ratios BDRX's Financial Strength Ratios BDRX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T09:28:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.